Graft SurvivalKidney TransplantationGraft RejectionImmunosuppressive AgentsTransplantation, HomologousSurvival RateCell SurvivalTissue DonorsLiver TransplantationCadaverTreatment OutcomeTime FactorsRetrospective StudiesLiving DonorsPancreas TransplantationGraft Occlusion, VascularCorneal TransplantationSurvival AnalysisHeart TransplantationKeratoplasty, PenetratingTissue and Organ ProcurementTacrolimusDisease-Free SurvivalHistocompatibility TestingImmunosuppressionSkin TransplantationCyclosporineFollow-Up StudiesDelayed Graft FunctionCold IschemiaIslets of Langerhans TransplantationPostoperative ComplicationsSurvivalOrgan PreservationKaplan-Meier EstimateMycophenolic AcidBrain DeathTransplantsReoperationTransplantation ToleranceTransplantation, HeterotopicProportional Hazards ModelsGraft Enhancement, ImmunologicLiver FailureBlood Vessel ProsthesisPrimary Graft DysfunctionAntilymphocyte SerumDeathTransplantation ImmunologyRisk FactorsKidney Failure, ChronicAzathioprineRats, Inbred LewIsoantibodiesHLA AntigensMice, Inbred C57BLPolytetrafluoroethyleneOrgan Preservation SolutionsMice, Inbred BALB CKidneyRecurrenceMultivariate AnalysisProspective StudiesDonor SelectionTransplantationAnastomosis, SurgicalHistocompatibilityPrognosisCreatinineTissue and Organ HarvestingTransplantation, IsogeneicCorneal NeovascularizationBiopsyVascular PatencyAge FactorsComplement C4bAntibodies, MonoclonalCohort StudiesRaffinoseIsoantigensImmunoconjugatesDrug Therapy, CombinationFetal Tissue TransplantationActuarial AnalysisAllograftsRisk AssessmentPolyethylene TerephthalatesSaphenous VeinBlood Vessel Prosthesis ImplantationIncidenceWaiting ListsAcute DiseaseApoptosisOrgan TransplantationSirolimusTransplantation, HeterologousPrednisoneDescemet Stripping Endothelial KeratoplastyImmunohistochemistryBrain Tissue Transplantation